WASHINGTON, D.C. -- FreedomWorks Foundation today announces the launch of its Most Favored Nations (MFN) Drug Price Controls Scorecard. The Scorecard notes the prevalence of four key indicators related to an MFN drug price control proposal: reduced access to meds, long wait times for health services, a single payer system, and equipment shortages. The preponderance of these characteristics in 17 other developed countries is noted on the scorecard.

WASHINGTON, D.C. -- As part of our ongoing effort to advance healthcare freedom, Sarah Anderson, FreedomWorks’ Director of Policy, hosted a series of online interviews with elected officials and health policy experts on the need for Congress to expand health savings accounts. Links to the online interviews with H.R. 6338 sponsors Reps. Ted Budd (R-N.C.) and Chip Roy (R-Texas) and Americans for Prosperity’s Dean Clancy are here and here.

WASHINGTON, D.C. -- In response to an executive order issued by President Trump ordering price controls to be placed on prescription drugs in America, Adam Brandon, FreedomWorks President commented:

WASHINGTON, D.C. -- In response to proposals by so-called free-market conservatives that call for the implementation of price controls on prescription drugs, FreedomWorks announces today a six-figure Hulu and digital ad buy calling on Congress and the administration to reject socialized price controls.